Dementia Drugs Market will grow at 8.4% CAGR, was valued at US$ 13,900.0 million in 2020 | Global Industry Analysis by Company Profiles, Segments, Size, Landscape and Demand

Dementia refers to the loss of memory, language, problem-solving, and other thinking abilities that are severe enough to interfere with daily life. Alzheimer’s is the most common cause of dementia. Though dementia mostly affects older adults, it is not a part of aging. Medication and therapies may help manage symptoms.

Request Here For PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1664

Drivers:

Increasing demand for safe and effective diagnosis and treatment, due to the increasing prevalence of Alzheimer’s with dementia, is expected to propel growth of the global dementia drugs market over the forecast period. The underdiagnoses rate in low- and middle-income economies is 10%. According to the 2016 World Alzheimer report, only 50% of patients suffering from dementia undergo diagnosis.

Moreover, disease-modifying mechanisms, advancing diagnostic capabilities, growing awareness among people about dementia, and increasing launches and approvals are also expected to drive the global dementia drugs market growth. For instance, in 2017, Zydus Cadila received the U.S. Food and Drug Administration (FDA) approval to market Donepezil Hydrochloride tablets used for the treatment of dementia in the United States.

Regional Analysis:

The global dementia drugs market, in the Asia Pacific, witnessing robust growth due to increasing incidence of dementia and government initiatives to provide better palliative care to patients.

In May 2017, Merck and Teijin Pharma entered into an exclusive license agreement to develop, manufacture, and commercialize an investigational preclinical antibody candidate targeting the protein tau. Changes in tau are associated with a number of diseases affecting the nervous system, including Alzheimer’s disease (AD).

Major Key Players Include In Dementia Drugs Market: Eisai, Inc., Janssen Pharmaceuticals, Inc., Biogen Pharmaceuticals, Forest Laboratories, Inc., Eli Lilly and Company, Novartis AG, Sanofi S.A., AstraZeneca GmbH, F. Hoffmann-La Roche, Merck & Co., Inc.., Valeant Pharmaceutical International, Pfizer Inc., and Teva Pharmaceuticals Industries Ltd.

Main points in Dementia Drugs Market Report Table of Content

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Dementia Drugs Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Dementia Drugs Industry Impact

Chapter 2 Global Dementia Drugs Competition by Types, Applications, and Top Regions and Countries
2.1 Global Dementia Drugs (Volume and Value) by Type
2.3 Global Dementia Drugs (Volume and Value) by Regions

Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis

Chapter 4 Global Dementia Drugs Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Dementia Drugs Market Analysis
Chapter 6 East Asia Dementia Drugs Market Analysis
Chapter 7 Europe Dementia Drugs Market Analysis
Chapter 8 South Asia Dementia Drugs Market Analysis
Chapter 9 Southeast Asia Dementia Drugs Market Analysis
Chapter 10 Middle East Dementia Drugs Market Analysis
Chapter 11 Africa Dementia Drugs Market Analysis
Chapter 12 Oceania Dementia Drugs Market Analysis
Chapter 13 South America Dementia Drugs Market Analysis
Chapter 14 Company Profiles and Key Figures in Dementia Drugs Business
Chapter 15 Global Dementia Drugs Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology

Buy instant copy of this research report with Flat US $ 2000 Off@  https://www.coherentmarketinsights.com/promo/buynow/1664

Reasons to Purchase this Report

• Current and future of Dementia Drugs Market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
Email: sales@coherentmarketinsights.com